1. Antoniw, P, Farnsworth, APH, Turner, A, Haines, AMR, Mountain, A, Mackintosh, J, Shochat, D, Humm, J, Welt, S, Old, LJ, Yarranton, GT & King, DJ (1996). Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttrium-90 A33 IgG and tri-Fab (TFM). Br J Cancer 74: 513–524.
2. Behr, TM, Sharkey, RM, Juweid, MI, Dunn, RM, Zhiliang, Y, Zhang, CH, Siegal, JA, Gold, DV & Goldenberg, DM (1995). Reduction of the renal uptake of radiolabelled monoclonal antibody fragments by cationic amino acids and their derivatives. Cancer Res 55: 3825–3834.
3. Buchsbaum, DJ & Order, SE (1990). Bone marrow dosimetry and toxicity for radioimmunotherapy. Antibody Immunoconj Radiopharm 3: 213–233.
4. Boxer, GM, Chester, KA, Robson, L, Keep, PA, Casey, JL & Begent, RHJ (1995). Non-cross reactive scFv anti-CEA antibody from a combinatorial bacteriophage library. Br J Cancer Suppl: P139 (Abstract 59).
5. Casey, JL, King, DJ, Chaplin, LC, Haines, AMR, Pedley, RB, Mountain, A, Yarranton, GT & Begent, RHJ (1996). Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab′ fragments. Br J Cancer 74: 1397–1405.